The effect of the cannabinoid receptor ligand WIN-55,212-2 on the TNF-α production by human mononuclear cells

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 67, Issue 2, 2004, Pages 49-50

  Isachenko, E G ^a   Vitkina, T I ^a   Berdyshev, E V ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF MARINE BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; CANNABINOID RECEPTOR; LIGAND; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; BIOSYNTHESIS; DRUG POTENTIATION; METABOLISM;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; MORPHOLINES; NAPHTHALENES; RECEPTORS, CANNABINOID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2542420843     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. A. Bendelac and R. H. Schwartz, J. Nature, 353, 68-71 (1991).
2. E. V. Berdyshev, P. C. Schmid, R. J. Krebsbach, et al., J. Biochem, 360, 67-75, (2001).
3. N. E. Buckley, K. L. McCoy, E. Mezey, et al., J. Pharmacl, 396, 141-149 (2000).
4. J. L. Bueb, D. M. Lambert, and E. J. Tschirhart, Biochim Biophys Acta, 1538, 252-259 (2001).
5. N. Germain, E. Boichot, C. Advenier, et al., International Immunopharmacology, No 2, 537-543 (2002).
6. A. C. Howlett, J. Annu. Rev. Pharmacol. Toxicol, 33, 607-634 (1995).
7. T. W. Klein, C. Newton, and H. Friedman, Immunol Today, 19, 373-381 (1998).
8. K. L. McCoy, M. Matveyeva, S. J. Carlisle, and G. A. Cabral, J. Pharmacol Exp Ther, 289, 1620-1625 (1999).
9. M. Rinaldi-Carmona, F. Barth, M. Heaulme, et al., J. Life Sci, 56, 1941-1947 (1995).
10. M. Rinaldi-Carmona, F. Barth, J. Millan, et al., J. Pharmacol Exp Ther, 284, 644-650 (1998).
11. M. Rouleau, F. Cittez, M. Bigler, et al., J. Immunol, 163, 1420-1427 (1999).
12. S. R. Smith, C. R. Terminelli, and G. Denhardt, J. Pharmacol Exp, 293, 136-150 (2000).
13. K. Varga, J. A. Wagner, D. T. Bridgen, and G. Kuno, J. FASEB, 12, 1035-1044 (1998).